Our study is broadly consistent with a recent report that showed an increase in the methylation rate of the XPO4 promoter accompanied by a reduction in transcription of the XPO4 gene in peripheral blood mononuclear cells (PBMCs) in association with the progression of hepatitis B infection and hepatocellular carcinoma development [8]. The gene discussed is XPO4; the disease is hepatitis B virus infection.